PwC appoints Ron Chopoorian as Global Leader, Health Industries

New York, 15 February 2021 – PwC has appointed Ron Chopoorian (PwC US) as the Global Leader of its Health Industries practice. Ron has extensive client experience and deep industry knowledge across health industries, including payer, provider and pharmaceutical and life sciences. He brings more than 24 years of experience assisting private equity and corporate clients with a broad range of mission critical strategic initiatives, including improving business and commercial strategy, mergers, acquisitions, and divestitures focused on improving shareholder value.  

In his new role, Chopoorian will lead the Global Health Industries team, which advises a large network of clients in healthcare and pharmaceuticals, as well as policymakers on a range of key areas including advanced data analytics, integrated patient experience, digital transformation in healthcare, social determinants of health, precision medicine, assurance, tax and legal services, and strategy. He will also continue his role as the Global Relationship Partner for one of the world’s largest multinational pharmaceutical companies. 

“I’m excited to take on the role of Global Health Industries Leader during a time when clients, policymakers and society face profound changes, challenges and opportunities,” says Chopoorian. “The COVID-19 pandemic serves as a reminder of how PwC’s purpose - to build trust in society and solve important problems - guides our work with health industries stakeholders. By bringing our capabilities together, we have a unique opportunity to connect payers, providers, pharma and policy makers in order to address common challenges across the health ecosystem. We can provide solutions that make a real impact in delivering the best outcomes for patients, communities and clients.” 

Kevin Burrowes, PwC’s Global Clients and Industries Leader, says “The opportunities and challenges facing our clients are unparalleled. In collaboration with other industries, our Health Industries practice, under Ron’s leadership, will continue to help governments and organisations repair, rethink and reconfigure their business models to emerge stronger from the crisis.”

Chopoorian previously was the New York Metro Deals Leader and has launched and served as the national leader of the PwC US Divestiture Services practice. He also co-led the “Digitizing Deals” initiative to enhance value creation and customer experience through the use and deployment of technology in the M&A process. During his career with PwC, he has advised various multinational pharmaceutical, biotechnology and medical device companies on a number of strategic and operational issues, from digital enablement and transformation to business and financial due diligence. 

Chopoorian earned a Bachelor of Business Administration degree in accounting from Southern Methodist University and a Master of Business Administration from Manchester Business School. Ron is also a CPA and a member of both the AICPA and the New York State Society of CPAs.

Notes

About PwC’s Global Health Industries: PwC has one of the world’s largest health networks, advising clients, which include policy makers, providers, payers and health sciences organisations, on how to meet the challenges of value, new entrants, digitisation and new global markets in their businesses. Our professionals include leading minds in medicine, pharmaceuticals, life sciences, information technology, clinical operations, business administration and health policy. As healthcare becomes increasingly interconnected with other industries, PwC’s global reach and resources help governments, businesses and industry players accomplish their missions in a dynamic and competitive environment. For more information, visit our Global Health Services and Pharmaceutical and Life Sciences pages.